Is There an Additional Value of SPECT/CT Over Planar Lymphoscintigraphy for Sentinel Node Mapping in Oral/Oropharyngeal Squamous Cell Carcinoma?

BackgroundLymphatic mapping for sentinel node biopsy (SNB) has been shown to be crucial for detection of sentinel lymph nodes (SLN). Previous reports suggested a benefit of single photon emission computed tomography with CT (SPECT/CT) over dynamic planar lymphoscintigraphy (LS) alone. The aim was to assess whether there is an additional value of SPECT/CT over LS alone for lymphatic mapping of SLNs in oral/oropharyngeal SCC.MethodsA consecutive cohort of 58 patients was evaluated using SNB with additional SPECT/CT to preoperative LS.ResultsIn the entire cohort of 58 patients undergoing LS and SPECT/CT, hot spots could be revealed in all but 4 cases. The guidance of the handheld gamma probe was able to reveal 9 additional SLNs within 3 patients not detected by either modality. Lymphoscintigraphy showed full concordance with SPECT/CT in 81% of the cases. SPECT/CT was able to detect additional HS in 11 patients, in 1 case even with additional metastatic disease. The false negative rate for SNB was 6%, and the negative predictive value 98%.ConclusionsSPECT/CT has the potential to detect more SLNs, which might harbor occult disease, than LS alone. With regard to the excellent results achieved with LS and the intraoperative use of the gamma probe, SPECT/CT is not indispensable for successful SNB. Both imaging modalities have difficulties in detecting level I sentinel nodes close to the injection site.

[1]  J. Marving,et al.  The role of SPECT-CT in the lymphoscintigraphic identification of sentinel nodes in patients with oral cancer , 2006, Acta oto-laryngologica.

[2]  M. Choti,et al.  Gamma probe-directed biopsy of the sentinel node in oral squamous cell carcinoma. , 1998, Archives of otolaryngology--head & neck surgery.

[3]  D. Dunaway,et al.  A suggested method for sentinel node biopsy in squamous cell carcinoma of the head and neck , 1999, Head & neck.

[4]  T. Poli,et al.  Sentinel Node Biopsy in Head and Neck Cancer: Preliminary Results of a Multicenter Trial , 2004, Annals of Surgical Oncology.

[5]  D. Krag,et al.  The gamma-probe-guided resection of radiolabeled primary lymph nodes. , 1996, Surgical oncology clinics of North America.

[6]  Z. Gil,et al.  Lymphoscintigraphy for sentinel node mapping using a hybrid single photon emission CT (SPECT)/CT system in oral cavity squamous cell carcinoma , 2006, Head & neck.

[7]  T. Kauppinen,et al.  Sentinel lymph node mapping using SPECT–CT fusion imaging in patients with oral cavity squamous cell carcinoma , 2006, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[8]  D. Soutar,et al.  The ability of lymphoscintigraphy to direct sentinel node biopsy in the clinically N0 neck for patients with head and neck squamous cell carcinoma. , 2002, The British journal of radiology.

[9]  Klemens Scheidhauer,et al.  SPECT-CT , 2008, Journal of Nuclear Medicine.

[10]  E. Even-Sapir,et al.  Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  G. Snow,et al.  Head and neck squamous cell carcinoma: US-guided fine-needle aspiration of sentinel lymph nodes for improved staging--initial experience. , 2001, Radiology.

[12]  Kurt Schicho,et al.  SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma. , 2004, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[13]  Umberto Veronesi,et al.  Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. , 2006, The Lancet. Oncology.

[14]  H. Steinert,et al.  Single-photon emission computed tomography/computed tomographyfor sentinel node mapping in breast cancer. , 2007, Seminars in nuclear medicine.

[15]  M. Gapany.  Sentinel Node Biopsy for Oral and Oropharyngeal Squamous Cell Carcinoma of the Head and Neck , 2008 .

[16]  P. Rutkowski,et al.  The Survival Benefit to Patients with Positive Sentinel Node Melanoma After Completion Lymph Node Dissection May Be Limited to the Subgroup with a Primary Lesion Breslow Thickness Greater Than 1.0 and Less Than or Equal to 4 mm (pT2–pT3) , 2008, Annals of Surgical Oncology.

[17]  D. Soutar,et al.  The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically N0 neck , 2001, Cancer.

[18]  D. Krag,et al.  Sentinel Lymph Node Radiolocalization in Head and Neck Squamous Cell Carcinoma , 2000, The Laryngoscope.

[19]  S. Stoeckli,et al.  Is there a role for positron emission tomography with 18F‐fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma , 2002, Head & neck.

[20]  S. Stoeckli,et al.  Sentinel Lymph Node Evaluation in Squamous Cell Carcinoma of the Head and Neck , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[21]  J. A. Sørensen,et al.  Sentinel lymph node biopsy in oral cancer: validation of technique and clinical implications of added oblique planar lymphoscintigraphy and/or tomography , 2005, Acta radiologica.